Received Feb 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | — | — |
experienced "a local reaction"; This spontaneous report was received from a Medical Assistant and refers to a 55-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 12-Dec-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), Solution for injection 0.5 mL, Single Dose via intramuscular route (lot # and expiration date were not reported) as pneumonia vaccination. On the same date (also reported as "they are unsure of when the patient's "local reaction" began"), the patient experienced "a local reaction". Medical Assistant stated the patient was not provided with any medical treatments and did not seek medical attention. The patient recovered from the event on an unspecified date. The action taken with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was not applicable. The causal relationship between the event of experienced "a local reaction" and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was unknown.